Molina Healthcare (NYSE:MOH) Updates FY 2025 Earnings Guidance

Key Points

• Molina Healthcare has updated its FY 2025 earnings guidance, projecting earnings per share of 14.00, significantly below the consensus estimate of 18.72.
• The company's revenue guidance for FY 2025 is set at $44.5 billion, slightly below the consensus estimate of $44.6 billion.
• Institutional ownership of Molina Healthcare is high, with 98.5% of the stock owned by institutional investors, including significant recent acquisitions by firms like Viking Global Investors and Man Group plc.

Molina Healthcare (NYSE:MOH - Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 14.000-14.000 for the period, compared to the consensus earnings per share estimate of 18.720. The company issued revenue guidance of $44.5 billion-$44.5 billion, compared to the consensus revenue estimate of $44.6 billion.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on the company. Sanford C. Bernstein dropped their target price on Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating for the company in a report on Friday, September 5th. UBS Group dropped their target price on Molina Healthcare from $260.00 to $180.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Barclays dropped their price objective on Molina Healthcare from $186.00 to $185.00 and set an "equal weight" rating for the company in a report on Thursday, September 4th. Mizuho dropped their price objective on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a report on Friday, July 11th. Finally, Robert W. Baird dropped their price objective on Molina Healthcare from $373.00 to $179.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Three analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $222.15.

Molina Healthcare Stock Down 1.1%

NYSE MOH traded down $2.23 on Wednesday, reaching $194.58. 2,694,664 shares of the stock traded hands, compared to its average volume of 1,037,292. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.66 and a current ratio of 1.66. The company has a fifty day moving average price of $183.60 and a 200-day moving average price of $242.04. The company has a market cap of $10.55 billion, a price-to-earnings ratio of 9.59 and a beta of 0.55. Molina Healthcare has a 12 month low of $151.95 and a 12 month high of $359.97.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, October 22nd. The company reported $1.84 earnings per share for the quarter, missing analysts' consensus estimates of $3.82 by ($1.98). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. Molina Healthcare has set its FY 2025 guidance at 14.000-14.000 EPS. As a group, research analysts forecast that Molina Healthcare will post 24.4 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, COO James Woys bought 10,000 shares of the firm's stock in a transaction on Monday, August 4th. The stock was acquired at an average cost of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares in the company, valued at approximately $11,591,176.14. This trade represents a 15.54% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Ronna Romney sold 700 shares of Molina Healthcare stock in a transaction on Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total value of $107,618.00. Following the sale, the director directly owned 17,131 shares of the company's stock, valued at approximately $2,633,719.94. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.26% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in MOH. Viking Global Investors LP bought a new position in shares of Molina Healthcare in the 2nd quarter worth $79,665,000. Man Group plc grew its stake in Molina Healthcare by 1,551.9% during the 2nd quarter. Man Group plc now owns 127,132 shares of the company's stock worth $37,873,000 after buying an additional 119,436 shares during the last quarter. Holocene Advisors LP grew its stake in Molina Healthcare by 61.9% during the 2nd quarter. Holocene Advisors LP now owns 128,912 shares of the company's stock worth $38,403,000 after buying an additional 49,304 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Molina Healthcare by 19.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company's stock worth $82,172,000 after buying an additional 40,531 shares during the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new position in Molina Healthcare during the 2nd quarter worth $9,842,000. 98.50% of the stock is owned by institutional investors.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.